JP2010536761A5 - - Google Patents

Download PDF

Info

Publication number
JP2010536761A5
JP2010536761A5 JP2010521050A JP2010521050A JP2010536761A5 JP 2010536761 A5 JP2010536761 A5 JP 2010536761A5 JP 2010521050 A JP2010521050 A JP 2010521050A JP 2010521050 A JP2010521050 A JP 2010521050A JP 2010536761 A5 JP2010536761 A5 JP 2010536761A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
solvate
stereoisomer
acceptable salt
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010521050A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010536761A (ja
JP5645663B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/009793 external-priority patent/WO2009023272A1/en
Publication of JP2010536761A publication Critical patent/JP2010536761A/ja
Publication of JP2010536761A5 publication Critical patent/JP2010536761A5/ja
Application granted granted Critical
Publication of JP5645663B2 publication Critical patent/JP5645663B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010521050A 2007-08-15 2008-08-15 ネクロトーシスのヘテロ環式抑制剤 Active JP5645663B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US95596607P 2007-08-15 2007-08-15
US60/955,966 2007-08-15
US3817508P 2008-03-20 2008-03-20
US61/038,175 2008-03-20
PCT/US2008/009793 WO2009023272A1 (en) 2007-08-15 2008-08-15 Heterocyclic inhibitors of necroptosis

Publications (3)

Publication Number Publication Date
JP2010536761A JP2010536761A (ja) 2010-12-02
JP2010536761A5 true JP2010536761A5 (xx) 2011-09-29
JP5645663B2 JP5645663B2 (ja) 2014-12-24

Family

ID=40351022

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010521050A Active JP5645663B2 (ja) 2007-08-15 2008-08-15 ネクロトーシスのヘテロ環式抑制剤

Country Status (5)

Country Link
US (5) US20090099242A1 (xx)
EP (2) EP3034494A1 (xx)
JP (1) JP5645663B2 (xx)
CA (1) CA2696349A1 (xx)
WO (1) WO2009023272A1 (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491743B2 (en) * 2003-08-29 2009-02-17 President And Fellows Of Harvard College Inhibitors of cellular necrosis
JP2009521454A (ja) * 2005-12-20 2009-06-04 プレジデント・アンド・フエローズ・オブ・ハーバード・カレツジ 化合物、スクリーニング、および処置方法
JP2012513481A (ja) 2008-12-23 2012-06-14 プレジデント アンド フェロウズ オブ ハーバード カレッジ ネクロトーシスの小分子阻害剤
EP2560629B1 (en) 2010-04-23 2020-06-03 Massachusetts Eye & Ear Infirmary Methods and compositions for preserving photoreceptor and retinal pigment epithelial cells
EP2580218B1 (en) 2010-06-11 2015-02-25 Rhodes Technologies Process for n-dealkylation of tertiary amines
EP2580201B1 (en) 2010-06-11 2017-08-02 Rhodes Technologies Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
WO2012061045A2 (en) 2010-11-01 2012-05-10 Massachusetts Eye And Ear Infirmary Methods and compositions for preserving retinal ganglion cells
WO2012125544A2 (en) 2011-03-11 2012-09-20 President And Fellows Of Harvard College Necroptosis inhibitors and methods of use therefor
EP2773341A2 (en) 2011-10-21 2014-09-10 Massachusetts Eye & Ear Infirmary Compositions comprising necrosis inhibitors, such as necrostatins, alone or in combination, for promoting axon regeneration and nerve function, thereby treating cns disorders
TWI637951B (zh) 2013-02-15 2018-10-11 英商葛蘭素史克智慧財產發展有限公司 作為激酶抑制劑之雜環醯胺類
US9725452B2 (en) 2013-03-15 2017-08-08 Presidents And Fellows Of Harvard College Substituted indoles and pyrroles as RIP kinase inhibitors
CN103535358B (zh) * 2013-10-18 2015-04-15 孙家隆 一组邻位取代苯甲酰化合物的杀菌剂用途
EA201791289A1 (ru) 2014-12-11 2017-12-29 Президент Энд Феллоуз Оф Гарвард Колледж Ингибиторы клеточного некроза и связанные с ними способы
CN107108492B (zh) 2014-12-24 2021-03-19 北京生命科学研究所 细胞坏死抑制剂
AU2015371822B2 (en) * 2014-12-24 2020-04-09 National Institute Of Biological Sciences, Beijing Necrosis inhibitors
IL247368A0 (en) 2016-08-18 2016-11-30 Yeda Res & Dev Diagnostic and therapeutic uses of exosomes
PT3788044T (pt) 2018-05-03 2023-08-31 Rigel Pharmaceuticals Inc Compostos inibidores de rip1 e métodos para preparar e usar os mesmos
HRP20230909T1 (hr) 2018-05-03 2023-12-08 Rigel Pharmaceuticals, Inc. Spojevi inhibitori rip1 i postupci za njihovo dobivanje i upotrebu
KR20210108955A (ko) 2018-11-20 2021-09-03 시로낙스 엘티디 Rip1 억제제
CN111978311B (zh) * 2019-05-21 2024-05-31 中国科学院上海有机化学研究所 一类细胞程序性坏死抑制剂及其制备方法和用途
JP7376218B2 (ja) 2019-09-06 2023-11-08 ライジェル ファーマシューティカルズ, インコーポレイテッド Rip1阻害化合物ならびにそれを作製および使用するための方法
EP4025575A1 (en) 2019-09-06 2022-07-13 Rigel Pharmaceuticals, Inc. Rip1 inhibitory compounds and methods for making and using the same
TW202132307A (zh) 2019-11-07 2021-09-01 美商雷傑製藥公司 雜環rip1抑制性化合物
TWI824259B (zh) 2020-07-01 2023-12-01 美商雷傑製藥公司 Rip1k抑制劑
US20240009149A1 (en) * 2020-11-19 2024-01-11 Acousia Therapeutics Gmbh Non-aqueous gel composition

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2728523C2 (de) * 1977-06-23 1986-02-27 Schering AG, 1000 Berlin und 4709 Bergkamen 4-Methyl-1,2,3-thiadiazol-5-carbonsäure-(cyclohexylmethyl)-amid, Mittel mit herbizider und wachstumsregulatorischer Wirkung enthaltend diese Verbindung sowie Verfahren zu seiner Herstellung
US4356787A (en) 1977-12-30 1982-11-02 Harley Richard C Float construction
JPH10152482A (ja) * 1996-09-30 1998-06-09 Nippon Nohyaku Co Ltd 1,2,3−チアジアゾール誘導体又はその塩類及び農園芸用病害防除剤ならびにその使用方法
DE69722019T2 (de) * 1996-09-30 2003-11-27 Nihon Nohyaku Co Ltd 1,2,3-thiadiazol-derivate und ihre salze, mittel zur kontrolle von krankheiten in landwirtschaft und gartenbau und eine methode zu ihrer anwendung
ATE228119T1 (de) * 1998-04-15 2002-12-15 Pfizer Prod Inc Heterocyclische carboxamide
EP0976326B1 (en) 1998-07-30 2003-05-02 Nihon Nohyaku Co., Ltd. Fungicidal composition containing a 1,2,3-tiadiazole derivative and its use
JP2000103710A (ja) * 1998-07-30 2000-04-11 Nippon Nohyaku Co Ltd 殺菌剤組成物及びその使用方法
US6756394B1 (en) * 1999-10-15 2004-06-29 President And Fellow Of Harvard College Small molecule inhibitors of necrosis
US6420400B1 (en) * 2000-04-07 2002-07-16 Kinetek Pharmaceuticals, Inc. Antiproliferative 1,2,3-thiadiazole compounds
WO2002085851A1 (fr) * 2001-04-19 2002-10-31 Sumitomo Pharmaceuticals Company, Limited Derive de type pyrrole
DE10132686A1 (de) * 2001-07-05 2003-01-16 Boehringer Ingelheim Pharma Heteroarylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
WO2003030937A1 (fr) * 2001-10-05 2003-04-17 Ono Pharmaceutical Co., Ltd. Remedes contre des maladies liees au stress comprenant des antagonistes de recepteurs mithochondriaux de la benzodiazepine
SI1474395T1 (sl) 2002-02-12 2008-02-29 Smithkline Beecham Corp Nikotinamidni derivati, uporabni kot inhibitorji p38
DE10261131A1 (de) * 2002-12-20 2004-07-01 Grünenthal GmbH Substituierte 5-Aminomethyl-1H-pyrrol-2-carbonsäureamide
GB0302671D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
US20060160794A1 (en) * 2003-06-12 2006-07-20 Amegadzie Albert K Tachykinin receptor antagonists
US7491743B2 (en) 2003-08-29 2009-02-17 President And Fellows Of Harvard College Inhibitors of cellular necrosis
US7462612B2 (en) * 2004-03-26 2008-12-09 Vertex Pharmaceuticals Incorporated Pyridine inhibitors of ERK2 and uses thereof
KR101155288B1 (ko) * 2004-07-30 2012-07-02 엑셀리시스, 인코포레이티드 의약제로서의 피롤 유도체
CN101163478B (zh) * 2005-01-25 2013-11-27 幸讬制药公司 用于炎症及免疫相关用途之化合物
PL1852428T3 (pl) * 2005-02-24 2012-10-31 Nihon Nohyaku Co Ltd Związek 4-cyklopropylo-1,2,3-tiadiazolowy, środek do zwalczania chorób roślin w rolnictwie i ogrodnictwie oraz sposób stosowania go
JP2009521454A (ja) * 2005-12-20 2009-06-04 プレジデント・アンド・フエローズ・オブ・ハーバード・カレツジ 化合物、スクリーニング、および処置方法
JP2007186435A (ja) * 2006-01-12 2007-07-26 Astellas Pharma Inc ニコチンアミド誘導体
JP2009524677A (ja) 2006-01-25 2009-07-02 シンタ ファーマシューティカルズ コーポレーション 炎症および免疫関連使用用のチアゾールおよびチアジアゾール化合物
EP1984338B8 (en) * 2006-01-31 2013-05-22 Synta Pharmaceuticals Corp. Pyridylphenyl compounds for inflammation and immune-related uses
AU2007227210A1 (en) * 2006-03-20 2007-09-27 Synta Pharmaceuticals Corp. Benzoimidazolyl-parazine compounds for inflammation and immune-related uses
WO2007112093A2 (en) * 2006-03-23 2007-10-04 Synta Pharmaceuticals Corp. Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
AU2007307044B2 (en) 2006-10-10 2014-03-20 President And Fellows Of Harvard College Compounds, screens, and methods of treatment
EP1995241B1 (en) * 2007-03-23 2010-03-17 ICAgen, Inc. Inhibitors of ion channels
WO2010075290A1 (en) 2008-12-22 2010-07-01 President And Fellows Of Harvard College Unsaturated heterocyclic inhibitors of necroptosis
JP2012513481A (ja) 2008-12-23 2012-06-14 プレジデント アンド フェロウズ オブ ハーバード カレッジ ネクロトーシスの小分子阻害剤

Similar Documents

Publication Publication Date Title
JP2010536761A5 (xx)
KR102435676B1 (ko) 독성 알데히드 관련된 질병 및 치료
JP6251259B2 (ja) 新規の5−アミノテトラヒドロキノリン−2−カルボン酸およびその使用
WO2017048954A1 (en) Hepatitis b core protein modulators
WO2016081649A1 (en) Thieno[2,3-d]pyrimidin-4-one derivatives as nmdar modulators and uses related thereto
JP2007527913A5 (xx)
JP2010522709A5 (xx)
JP2008513496A5 (xx)
WO2008054454A2 (en) Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents
JP2016512531A5 (xx)
JP2019512474A (ja) シアノ置換インドール化合物およびlsd1阻害剤としてのその使用
JP2006528617A5 (xx)
JP2010522711A5 (xx)
JP2015508092A5 (xx)
JP2010516702A5 (xx)
JP2010522710A5 (xx)
RU2007132438A (ru) Циклопропил-(2,3-диметилбензил)амид 7-{4-[2-(2,6-дихлор-4-метилфенокси)этокси]фенил}-3,9-диазабицикло[3.3.1]нон-6-ен-6-карбоновой кислоты в качестве ингибиторов ренина для лечения артериальной гипертензии
JP2010504351A5 (xx)
JP2016516792A (ja) α−2アドレノレセプターおよびシグマレセプターリガンドの組み合わせ物
JP2010522214A5 (xx)
CA2956118A1 (en) Aldosterone synthase inhibitors
JP2010513489A5 (xx)
JP2009536967A5 (xx)
JP6518692B2 (ja) 多環式herg活性化剤
CN107108560B (zh) 化合物、组合物及其方法